Analyst Price Targets — HCAT
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| June 26, 2026 10:01 am | Stan Berenshteyn | Wells Fargo | $1.75 | $1.77 | TheFly | Health Catalyst price target raised to $1.75 from $1 at Wells Fargo |
| May 12, 2026 11:33 am | — | Stephens | $1.75 | $1.38 | TheFly | Health Catalyst price target lowered to $1.75 from $2 at Stephens |
| March 13, 2026 11:24 am | Sarah James | Raymond James | $3.00 | $1.79 | StreetInsider | Health Catalyst Inc. (HCAT) PT Lowered to $3 at Cantor Fitzgerald; No Turnaround Yet |
| March 13, 2026 11:14 am | Richard Close | Canaccord Genuity | $2.00 | $1.79 | StreetInsider | Health Catalyst Inc. (HCAT) PT Lowered to $2 at Canaccord |
| October 8, 2025 12:11 pm | — | Evercore ISI | $3.00 | $2.90 | TheFly | Health Catalyst price target lowered to $3 from $4 at Evercore ISI |
| October 8, 2025 10:41 am | — | KeyBanc | $4.00 | $2.85 | TheFly | Health Catalyst price target lowered to $4 from $5 at KeyBanc |
| August 29, 2025 10:38 am | Richard Close | Canaccord Genuity | $5.00 | $3.65 | TheFly | Health Catalyst price target lowered to $5 from $9 at Canaccord |
| August 29, 2025 10:38 am | — | Summit Redstone Partners | $5.00 | $3.65 | TheFly | Health Catalyst price target lowered to $5 from $9 at Canaccord |
| April 16, 2025 11:02 am | Scott Schoenhaus | KeyBanc | $5.00 | $3.75 | TheFly | Health Catalyst price target lowered to $5 from $7 at KeyBanc |
| March 6, 2025 12:10 pm | — | Stephens | $5.00 | $4.43 | TheFly | Health Catalyst price target lowered to $5 from $7 at Stephens |
Latest News for HCAT
Health Catalyst NASDAQ: HCAT stockholders approved three of four proposals presented at the company's 2026 annual meeting, including the election of two directors, ratification of the company's auditor and an advisory vote on executive compensation. A proposal to phase out the company's classified board structure did not receive the required level of support.
SALT LAKE CITY, June 16, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that members of senior management will participate in the Truist Securities Healthcare Disruptors & Digital Health Conference, including a panel discussion titled “AI ROI in Healthcare: Real vs…
PARSIPPANY, N.J., June 4, 2026 /PRNewswire/ -- Med-Metrix, LLC ("Med-Metrix"), backed by Harvest Partners and A&M Capital Partners, today announced it has entered into a definitive agreement to acquire Vitalware, an industry-leading revenue workflow and analytics software business owned by Health Catalyst (NASDAQ: HCAT).
Health Catalyst today announced it has signed a definitive agreement to divest Vitalware, its mid-revenue cycle business, to Med-Metrix for $147 million.
Health Catalyst, Inc. (HCAT) Q1 2026 Earnings Call Transcript
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for HCAT.
U.S. House Trading
No House trades found for HCAT.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.